ImmuPharma plc (LSE: IMM) advanced 12.50% to 4.5p after a tangible development milestone for its diabetes programme. On 22 July 2026, the company selected Thermo Fisher Scientific's Patheon services as drug-product contract development and manufacturing organisation for Kapiglucagon. The appointment followed the earlier selection …
Tristel plc (LSE: TSTL) jumped 14.65% to 450p after issuing a positive trading update for the year ended 30 June 2026. The catalyst was straightforward: management expects revenue of about £51.1 million, 10% above the prior year, and adjusted profit before tax of at …
AOTI, Inc. (LSE: AOTI) rose 32.58% to 87.5p after US Medicare administrative contractors issued a proposed nationwide Local Coverage Determination for topical oxygen therapy in eligible diabetic foot ulcers. The development is directly relevant to AOTI's TWO2 system and could widen reimbursement. It is …
ImmuPharma plc is a UK-based biotechnology company focused on developing novel therapeutics for autoimmune diseases, metabolic disorders and other areas of unmet medical need. The company's shares moved higher as investors responded positively to recent operational developments, growing confidence in its development programmes and …
AOTI, Inc. is a medical technology company specializing in advanced wound-care solutions designed to improve outcomes for patients suffering from chronic and difficult-to-heal wounds. Its proprietary therapy platform has established a differentiated position within the wound management market by combining innovative treatment technology with …
LSE:OBD – Oxford BioDynamics Plccame under heavy selling pressure after its shares fell12.00%during trading on24 July 2026.
LSE:PRM – Proteome Sciences plcattracted significant market attention after its shares fell15.79%during trading on24 July 2026.
LSE:PXS – Provexis PLCattracted investor attention after its shares declined10.00%during trading on24 July 2026.
Renalytix Plc gained5.66%on24 July 2026as investors continued favouring healthcare technology companies developing advanced diagnostic solutions supported by artificial intelligence and precision medicine.
• Aptamer Group plc (LSE:APTA) advanced approximately8.11%on24 July 2026, ranking among the strongest-performing UK healthcare stocks.